Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada

Overview of attention for article published in BMC Pharmacology and Toxicology, June 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 34 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 8,539 followers.

Sorry this is the article I was trying to link to https://t.co/GEXiOyYvw6

22 Jun 2020

Reply Repost Favourite

Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toront... https://t.co/OMVoKzDJos

31 Jan 2020

Reply Repost Favourite

Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada https://t.co/wCgMVt9pRp #ScientiaVH @vallhebron

01 Aug 2019

Reply Repost Favourite

Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada. - PubMed - NCBI https://t.co/i7RpbaRyYM #hvhebron #medint @BMC_series [Text complet]

06 Jun 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.